Abstract
BackgroundCorticosteroid (CS) is effective for controlling inflammatory reactions in SLE, but may have been known to increase risk of avascular necrosis (AVN) in patients with Systemic lupus erythematosus (SLE). This...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
